Search filters

Filters
Clear All

Phase

  • 1
  • 3
  • 2
  • 6
  • 3
  • 1
  • 5

Found 6 Blood Transfusions trials

A listing of Blood Transfusions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

 SMaRT Blood: Single-unit versus Multiple-unit pRBC Transfusion in non-acute postpartum anemia
18 years - 50 years
Female
Interventional
Blood transfusion is often recommended for women who have anemia (low blood counts) after delivering a baby. Currently, many doctors give 2 units, or packets, of blood because they expect that everyone will need 2. However, it may be better to only give 1 unit at a time to raise …
99 years or below
All genders
Phase 2
This is a Phase 2 open-label, single-arm design with dose escalation by subject cohort and with the potential for individual titration (dose increase or decrease) within each cohort. Five PTG-300 dose levels/regimens are planned to be tested for each subpopulation of beta-thalassemia (NTD and TD) on separate arms: Cohort 1: …
99 years or below
All genders
Phase 3
To compare the effect of mitapivat versus placebo on transfusion burden in subjects with alpha- or beta-transfusiondependent thalassemia (TDT) Transfusion reduction response (TRR), defined as a 50% reduction in transfused red blood cell (RBC) units with a reduction of greater that or equal to 2 units of transfused RBCs in …
99 years or below
All genders
Phase 3
The primary safety objective is a composite of the number of Major Adverse Events (MAEs) occurring through 30 days post-procedure compared to the rate in subjects treated with the Relay Thoracic Stent-Graft in the U.S. Pivotal Trial (P110038). The primary effectiveness objective is a composite of the number of effectiveness …
18 years - 65 years
All genders
Phase 3
Interventional
The Study Product we are testing in this research study is called STx-02. This study is being done to learn more about how safe, tolerable and effective the Study Product is in participants with T1D with impaired awareness of low blood sugar and who have severe hypoglycemia. Participation could last …
18 years or above
All genders
Observational
This study will be a retrospective chart review of patients who have been diagnosed with benign or malignant pancreatic disease under the practice of Dr. Rohan Jeyarajah, M.D., Dr. Houssam Osman M.D., and Dr. Edward Cho M.D., Sc.M. at Methodist Health System Hospital in Richardson, TX. The Investigators plan to …